Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""AZATHIOPRINE"" wg kryterium: Temat


Starter badań:

Tytuł :
Debulking Surgery Combined with Low-Dose Oral Prednisolone and Azathioprine for Intractable IgG4-Related Orbital Disease: A Case Report.
Autorzy :
Kuo HH; Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
Chen CH; Division of Allergy, Immunology and Rheumatology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.; School of Medicine, Tzu Chi University, Hua-Liang County 970, Taiwan.
Wu SY; Department of Ophthalmology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
Pokaż więcej
Źródło :
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 May 04; Vol. 57 (5). Date of Electronic Publication: 2021 May 04.
Typ publikacji :
Case Reports
MeSH Terms :
Azathioprine*/therapeutic use
Orbital Diseases*
Cytoreduction Surgical Procedures ; Humans ; Immunoglobulin G ; Male ; Middle Aged ; Prednisolone/therapeutic use
Raport
Tytuł :
Insights on chronic hypersensitivity pneumonitis' treatment: Factors associated with a favourable response to azathioprine.
Autorzy :
Raimundo S; Pulmonology Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal. Electronic address: .
Pimenta AC; Pulmonology Department, Centro Hospitalar de Trás-os-Montes e Alto Douro, Vila Real, Portugal.
Cruz-Martins N; Faculty of Medicine, University of Porto, Porto, Portugal; Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Laboratory of Neuropsychophysiology, Faculty of Psychology and Education Sciences, University of Porto, 4200-135 Porto, Portugal. Electronic address: .
Rodrigues MC; Radiology Department, Centro Hospitalar São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Melo N; Pneumology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.
Mota PC; Faculty of Medicine, University of Porto, Porto, Portugal; Pneumology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal. Electronic address: .
Sokhatska O; Basic and Clinical Immunology Unit, Department of Pathology, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Bastos HN; Faculty of Medicine, University of Porto, Porto, Portugal; Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Pneumology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.
Beltrão M; Basic and Clinical Immunology Unit, Department of Pathology, Faculdade de Medicina, Universidade do Porto, Porto, Portugal. Electronic address: .
Guimarães S; Pathology Department, Centro Hospitalar São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Moura CS; Pathology Department, Centro Hospitalar São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Cunha R; Radiology Department, Centro Hospitalar São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Pereira JM; Radiology Department, Centro Hospitalar São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Morais A; Faculty of Medicine, University of Porto, Porto, Portugal; Institute for Research and Innovation in Health, University of Porto, Porto, Portugal; Pneumology Department, Centro Hospitalar e Universitário de São João, Porto, Portugal.
Pokaż więcej
Źródło :
Life sciences [Life Sci] 2021 May 01; Vol. 272, pp. 119274. Date of Electronic Publication: 2021 Feb 20.
Typ publikacji :
Journal Article
MeSH Terms :
Alveolitis, Extrinsic Allergic/*drug therapy
Azathioprine/*pharmacology
Adult ; Aged ; Alveolitis, Extrinsic Allergic/diagnosis ; Alveolitis, Extrinsic Allergic/physiopathology ; Azathioprine/metabolism ; Biomarkers, Pharmacological ; Bronchoalveolar Lavage/methods ; Bronchoalveolar Lavage Fluid/cytology ; Chronic Disease ; Cohort Studies ; Female ; Humans ; Lymphocytosis/metabolism ; Male ; Middle Aged ; Retrospective Studies ; Tomography, X-Ray Computed/methods ; Vital Capacity/drug effects
Czasopismo naukowe
Tytuł :
Effect of IBD medications on COVID-19 outcomes: results from an international registry.
Autorzy :
Ungaro RC; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA .
Brenner EJ; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Gearry RB; Department of Medicine, University of Otago, Christchurch, New Zealand.
Kaplan GG; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Kissous-Hunt M; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.; Fifth Ave GI, New York, New York, USA.
Lewis JD; Division of Gastroenterology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Ng SC; Department of Medicine and Therapeutics, Institute of Digestive Disease, State Key Laboratory of Digestive Disease, Li Ka Shing Institute of Health Science, Chinese University of Hong Kong, Shatin, NT, Hong Kong.
Rahier JF; Department of Gastroenterology, Université Catholique de Louvain, Yvoir, Belgium.
Reinisch W; Department of Medicine IV, Medical University Vienna, Vienna, Austria.
Steinwurz F; Department of Gastroenterology, Hospital Israelita Albert Einstein, Sao Paulo, Brazil.
Underwood FE; Departments of Medicine and Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.
Zhang X; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Colombel JF; The Henry D Janowitz Division of Gastroenterology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Kappelman MD; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Pokaż więcej
Źródło :
Gut [Gut] 2021 Apr; Vol. 70 (4), pp. 725-732. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Azathioprine*/administration & dosage
Azathioprine*/adverse effects
COVID-19*/diagnosis
COVID-19*/epidemiology
COVID-19*/immunology
Inflammatory Bowel Diseases*/drug therapy
Inflammatory Bowel Diseases*/virology
Mercaptopurine*/administration & dosage
Mercaptopurine*/adverse effects
SARS-CoV-2*/drug effects
SARS-CoV-2*/isolation & purification
Tumor Necrosis Factor Inhibitors*/administration & dosage
Tumor Necrosis Factor Inhibitors*/adverse effects
Adult ; Anti-Inflammatory Agents/pharmacology ; Drug Therapy, Combination/methods ; Drug Therapy, Combination/statistics & numerical data ; Female ; Humans ; International Cooperation ; Male ; Registries/statistics & numerical data ; Risk Adjustment ; Severity of Illness Index
Czasopismo naukowe
Tytuł :
Azathioprine-induced toxoplasma gondii infection in a patient with Crohn's disease with NUDT15 variation: A case report.
Autorzy :
Wu Y; Department of Gastroenterology, The Second Xiangya Hospital.; Research Center of Digestive Disease, Central South University, Changsha, Hunan 410011, China.
Tan Y; Department of Gastroenterology, The Second Xiangya Hospital.; Research Center of Digestive Disease, Central South University, Changsha, Hunan 410011, China.
Ou D; Department of Gastroenterology, The Second Xiangya Hospital.; Research Center of Digestive Disease, Central South University, Changsha, Hunan 410011, China.
Wang X; Department of Gastroenterology, The Second Xiangya Hospital.; Research Center of Digestive Disease, Central South University, Changsha, Hunan 410011, China.
Wang Y; Department of Gastroenterology, The Second Xiangya Hospital.; Research Center of Digestive Disease, Central South University, Changsha, Hunan 410011, China.
Pokaż więcej
Źródło :
Medicine [Medicine (Baltimore)] 2021 May 07; Vol. 100 (18), pp. e25781.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Azathioprine/*adverse effects
Crohn Disease/*drug therapy
Pneumonia/*diagnosis
Pyrophosphatases/*genetics
Toxoplasma/*immunology
Toxoplasmosis/*diagnosis
Azathioprine/pharmacokinetics ; Crohn Disease/genetics ; Crohn Disease/immunology ; DNA Mutational Analysis ; Humans ; Male ; Middle Aged ; Mutation ; Pharmacogenomic Testing ; Pneumonia/genetics ; Pneumonia/immunology ; Pneumonia/parasitology ; Polymorphism, Single Nucleotide ; Pyrophosphatases/metabolism ; Toxoplasma/isolation & purification ; Toxoplasmosis/genetics ; Toxoplasmosis/immunology ; Toxoplasmosis/parasitology
Czasopismo naukowe
Tytuł :
[Safe Handling Method for Splitting Azathioprine Tablets].
Autorzy :
Aoki M; Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University.; Department of Pharmacy, Kitasato University Medical Center.
Oda S; Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University.
Kubota S; Department of Pharmacy, Kitasato University Medical Center.
Saito S; Department of Pharmacy, Kitasato University Medical Center.
Yokota N; Department of Pharmacy, Kitasato University Medical Center.
Shibazaki A; Department of Pharmacy, Kitasato University Medical Center.
Shibuya K; Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University.; Department of Pharmacy, Kitasato University Medical Center.
Sako M; Ohara Pharmaceutical Co., Ltd.
Otori K; Department of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University.; Department of Pharmacy, Kitasato University Medical Center.
Pokaż więcej
Źródło :
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan [Yakugaku Zasshi] 2021; Vol. 141 (1), pp. 125-133.
Typ publikacji :
Journal Article
MeSH Terms :
Azathioprine*/adverse effects
Immunosuppressive Agents*/adverse effects
Drug Compounding/*methods
Drug Contamination/*prevention & control
Drug Packaging/*methods
Occupational Exposure/*prevention & control
Tablets
Czasopismo naukowe
Tytuł :
Precision medicine for rheumatologists: lessons from the pharmacogenomics of azathioprine.
Autorzy :
Daniel LL; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center (LLD, ALD, CPC), Nashville, TN, 37232, USA.
Dickson AL; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center (LLD, ALD, CPC), Nashville, TN, 37232, USA.
Chung CP; Department of Medicine, Division of Rheumatology, Vanderbilt University Medical Center (LLD, ALD, CPC), Nashville, TN, 37232, USA. .; Tennessee Valley Healthcare System-Nashville Campus (CPC), Nashville, TN, USA. .; Vanderbilt Genetics Institute, Vanderbilt University School of Medicine (CPC), Nashville, TN, USA. .
Pokaż więcej
Źródło :
Clinical rheumatology [Clin Rheumatol] 2021 Jan; Vol. 40 (1), pp. 65-73. Date of Electronic Publication: 2020 Jul 02.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Azathioprine*/adverse effects
Pharmacogenetics*
Humans ; Immunosuppressive Agents/adverse effects ; Precision Medicine ; Rheumatologists
Czasopismo naukowe
Tytuł :
Development of a HPLC-DAD stability-indicating method and compatibility study of azathioprine and folic acid as a prerequisite for a monolayer fixed-dose combination.
Autorzy :
Brusač E; University of Zagreb Faculty of Pharmacy of Biochemistry, A. Kovačića 1, 10000 Zagreb, Croatia. .
Jeličić ML
AmidŽić Klarić D
Nigović B
Keser S
Mornar A
Pokaż więcej
Źródło :
Analytical methods : advancing methods and applications [Anal Methods] 2021 Mar 21; Vol. 13 (11), pp. 1422-1431. Date of Electronic Publication: 2021 Mar 09.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Azathioprine*
Folic Acid*
Calorimetry, Differential Scanning ; Chromatography, High Pressure Liquid
Czasopismo naukowe
Tytuł :
Complete remission of refractory pemphigus vulgaris in a Chinese patient with mutated NUDT15 by combination of minimal doses of azathioprine and prednisone.
Autorzy :
Zhou XL; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Zhan TY; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Zhou YH; Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.
Shrestha K; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Lan TJ; West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Li W; Department of Dermatology, Rare Diseases Center, West China Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło :
Dermatologic therapy [Dermatol Ther] 2020 Nov; Vol. 33 (6), pp. e14079. Date of Electronic Publication: 2020 Sep 04.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Azathioprine*
Pemphigus*/diagnosis
Pemphigus*/drug therapy
Pemphigus*/genetics
Asian Continental Ancestry Group/genetics ; China ; Humans ; Male ; Prednisone
Czasopismo naukowe
Tytuł :
Efficacy and safety of azathioprine for neuromyelitis optica spectrum disorders: A meta-analysis of real-world studies.
Autorzy :
Luo D; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Wei R; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Tian X; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Chen C; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Ma L; Department of Pharmacy, Peking University First Hospital, Beijing, China.
Li M; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Dong X; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Zhang E; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China.
Zhou Y; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China. Electronic address: .
Cui Y; Department of Pharmacy, Peking University First Hospital, Beijing, China; College of Pharmacy, Peking University, Beijing, China. Electronic address: .
Pokaż więcej
Źródło :
Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2020 Nov; Vol. 46, pp. 102484. Date of Electronic Publication: 2020 Sep 03.
Typ publikacji :
Journal Article; Meta-Analysis
MeSH Terms :
Azathioprine*/therapeutic use
Neuromyelitis Optica*/drug therapy
China ; Humans ; Immunosuppressive Agents/adverse effects ; Recurrence
Czasopismo naukowe
Tytuł :
Prednisone and azathioprine in patients with inflammatory cardiomyopathy: systematic review and meta-analysis.
Autorzy :
Timmermans P; Department of Cardiology, Jessa Hospital, Hasselt, Belgium.; University Hospital Gasthuisberg, Leuven, Belgium.
Barradas-Pires A; Royal Brompton and Harefield NHS Foundation Trust, London, UK.
Ali O; Detroit Medical Center, Department of Cardiology, Wayne State University School of Medicine.
Henkens M; Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
Heymans S; Department of Cardiology, CARIM School for Cardiovascular Diseases, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology, Catholic University of Leuven, Leuven, Belgium.
Negishi K; Menzies Institute for Medical Research, University of Tasmania, Hobart, Australia.; Nepean Clinical School, The University of Sydney, Kingswood, Sydney, Australia.
Pokaż więcej
Źródło :
ESC heart failure [ESC Heart Fail] 2020 Oct; Vol. 7 (5), pp. 2278-2296. Date of Electronic Publication: 2020 Jul 27.
Typ publikacji :
Journal Article; Meta-Analysis; Systematic Review
MeSH Terms :
Azathioprine*
Myocarditis*
Humans ; Immunosuppressive Agents ; Prednisone
Czasopismo naukowe
Tytuł :
Azathioprine in combination with methotrexate may not be a good therapeutic alternative in severe and recalcitrant forms of alopecia areata.
Autorzy :
Ansari F; Department of Dermatology, Venereology & Leprology, All India Institute of Medical Sciences, Jodhpur, India.
Singh S; Department of Dermatology, Venereology & Leprology, All India Institute of Medical Sciences, Jodhpur, India.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Dec; Vol. 34 (12), pp. e814-e815. Date of Electronic Publication: 2020 Jun 22.
Typ publikacji :
Letter
MeSH Terms :
Alopecia Areata*/drug therapy
Azathioprine*
Humans ; Methotrexate
Opinia redakcyjna
Tytuł :
Azathioprine immunosuppression and disease modification in Parkinson's disease (AZA-PD): a randomised double-blind placebo-controlled phase II trial protocol.
Autorzy :
Greenland JC; Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK .
Cutting E; Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK.; Cambridge Clinical Trials Unit, Cambridge, Cambridgeshire, UK.
Kadyan S; Cambridge Clinical Trials Unit, Cambridge, Cambridgeshire, UK.
Bond S; Cambridge Clinical Trials Unit, Cambridge, Cambridgeshire, UK.
Chhabra A; Department of Pharmacy, Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, UK.
Williams-Gray CH; Department of Clinical Neurosciences, University of Cambridge, Cambridge, Cambridgeshire, UK.
Pokaż więcej
Źródło :
BMJ open [BMJ Open] 2020 Nov 23; Vol. 10 (11), pp. e040527. Date of Electronic Publication: 2020 Nov 23.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Azathioprine*/therapeutic use
Immunosuppressive Agents*/therapeutic use
Parkinson Disease*/drug therapy
Double-Blind Method ; Humans ; Immunosuppression ; Quality of Life ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Utility of azathioprine, methotrexate and cyclosporine as steroid-sparing agents in chronic alopecia areata: a retrospective study of continuation rates in 138 patients.
Autorzy :
Lai VWY; Department of Medicine, Alfred Hospital, Melbourne, Vic., Australia.
Sinclair R; Sinclair Dermatology, East Melbourne, Vic., Australia.
Pokaż więcej
Źródło :
Journal of the European Academy of Dermatology and Venereology : JEADV [J Eur Acad Dermatol Venereol] 2020 Nov; Vol. 34 (11), pp. 2606-2612. Date of Electronic Publication: 2020 Sep 01.
Typ publikacji :
Journal Article
MeSH Terms :
Alopecia Areata*/drug therapy
Azathioprine*/therapeutic use
Cyclosporine/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Methotrexate/therapeutic use ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Cost-effectiveness analysis of pretreatment screening for NUDT15 defective alleles.
Autorzy :
Zarca K; Assistance Publique-Hôpitaux de Paris, DRCI-URC Eco Ile-de-France (AP-HP), Paris.; Assistance Publique-Hôpitaux de Paris, Service de Santé Publique, Henri Mondor-Albert-Chennevier, Créteil.
Chansavang A; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Biochimie.
Loriot MA; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Biochimie.; Université de Paris, Paris, France.
Durand-Zaleski I; Assistance Publique-Hôpitaux de Paris, DRCI-URC Eco Ile-de-France (AP-HP), Paris.; Assistance Publique-Hôpitaux de Paris, Service de Santé Publique, Henri Mondor-Albert-Chennevier, Créteil.
Pallet N; Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Biochimie.; Université de Paris, Paris, France.
Pokaż więcej
Źródło :
Pharmacogenetics and genomics [Pharmacogenet Genomics] 2020 Oct; Vol. 30 (8), pp. 175-183.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Azathioprine/*adverse effects
Bone Marrow Diseases/*diagnosis
Drug Hypersensitivity/*diagnosis
Genotyping Techniques/*economics
Inflammatory Bowel Diseases/*drug therapy
Methyltransferases/*genetics
Pyrophosphatases/*deficiency
Asian Continental Ancestry Group/genetics ; Azathioprine/pharmacokinetics ; Bone Marrow Diseases/chemically induced ; Bone Marrow Diseases/genetics ; Cost-Benefit Analysis ; Decision Trees ; Drug Hypersensitivity/genetics ; European Continental Ancestry Group/genetics ; France/ethnology ; Genotyping Techniques/methods ; High-Throughput Nucleotide Sequencing/economics ; Humans ; Inflammatory Bowel Diseases/genetics ; Monte Carlo Method ; Sequence Analysis, DNA/economics
Czasopismo naukowe
Tytuł :
A rare case of refractory asthma managed with azathioprine.
Autorzy :
Kalra SS; Department of Pulmonary and Critical Care Medicine, University of Florida, Gainesville, FL, USA.
Lamia I; Department of Pulmonary and Critical Care Medicine, Cleveland Clinic Foundation, Cleveland, OH, USA.
Pokaż więcej
Źródło :
The Journal of asthma : official journal of the Association for the Care of Asthma [J Asthma] 2020 Sep; Vol. 57 (9), pp. 1039-1041. Date of Electronic Publication: 2019 Jun 14.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Anti-Asthmatic Agents/*pharmacology
Asthma/*drug therapy
Azathioprine/*therapeutic use
Drugs, Investigational/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Anti-Asthmatic Agents/therapeutic use ; Azathioprine/pharmacology ; Drug Resistance ; Drugs, Investigational/pharmacology ; Female ; Glucocorticoids/pharmacology ; Glucocorticoids/therapeutic use ; Humans ; Immunosuppressive Agents/pharmacology ; Middle Aged ; Prednisone/pharmacology ; Prednisone/therapeutic use ; Treatment Outcome
Czasopismo naukowe
Tytuł :
High discontinuation rate of azathioprine in autoimmune hepatitis, independent of time of treatment initiation.
Autorzy :
Pape S; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Gevers TJG; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Vrolijk JM; Department of Gastroenterology and Hepatology, Rijnstate Hospital, Arnhem, The Netherlands.
van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
Bouma G; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
van Nieuwkerk CMJ; Department of Gastroenterology and Hepatology, VU University Medical Center, Amsterdam, The Netherlands.
Taubert R; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Jaeckel E; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Papp M; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Sipeki N; Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
Stickel F; Department of Gastroenterology and Hepatology, University Hospital of Zurich, Zurich, Switzerland.
Efe C; Department of Gastroenterology, Harran University Hospital, Urfa, Turkey.
Ozaslan E; Department of Gastroenterology, Numune Research and Education Hospital, Ankara, Turkey.
Purnak T; Department of Gastroenterology, Hacettepe University, Ankara, Turkey.
Nevens F; Department of Gastroenterology and Hepatology, University Hospital KU Leuven, Leuven, Belgium.; European Reference Network RARE-LIVER, Hamburg, Germany.
Kessener DJN; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Kahraman A; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Wedemeyer H; Department of Gastroenterology and Hepatology, University Clinic of Essen Duisburg, Essen, Germany.
Hartl J; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Schramm C; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Martin Zeitz Centre for Rare Diseases, University Medical Centre Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Lohse AW; 1st Department of Internal Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; European Reference Network RARE-LIVER, Hamburg, Germany.
Heneghan MA; Institute of Liver Studies, King's College Hospital, London, UK.; European Reference Network RARE-LIVER, Hamburg, Germany.
Drenth JPH; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.; European Reference Network RARE-LIVER, Hamburg, Germany.
Pokaż więcej
Źródło :
Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2020 Sep; Vol. 40 (9), pp. 2164-2171. Date of Electronic Publication: 2020 Jun 11.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Azathioprine*
Hepatitis, Autoimmune*/drug therapy
Europe ; Humans ; Immunosuppressive Agents/adverse effects ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Autorzy :
Belizna C; Vascular and Coagulation Department, University Hospital Angers, Angers, France; MITOVASC institute and CARFI facility, University of Angers, UMR CNRS 6015, INSERM U1083, Angers, France; Internal Medicine Department, Clinique de l'Anjou, Angers, France; UMR CNRS 6015, Angers, France; INSERM U1083, Angers, France. Electronic address: .
Meroni PL; Clinical Immunology and Rheumatology Research Department Auxologico Institute, Milan, Italy.
Shoenfeld Y; The Zabludowicz Center for Autoimmune Diseases, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University, Israel; I.M. Sechenow First Moscow State Medical University, Moscow, Russia.
Devreese K; Coagulation Laboratory, Department of Clinical Biology, Immunology and Microbiology, Ghent University Hospital, Ghent, Belgium.
Alijotas-Reig J; Systemic Autoimmune Disease Unit, Department of Internal Medicine, Vall d'Hebron University Hospital, Barcelona, Spain; Department of Medicine, Universitat Autonòma, Barcelona, Spain.
Esteve-Valverde E; Internal Medicine Althaia Healthcare Network of Manresa, Barcelona, Spain.
Chighizola C; Clinical Immunology and Rheumatology Research Department Auxologico Institute, Milan, Italy.
Pregnolato F; Clinical Immunology and Rheumatology Research Department Auxologico Institute, Milan, Italy.
Cohen H; Haematology Department, University College Hospital, London, UK.
Fassot C; Internal Medicine Department, Clinique de l'Anjou, Angers, France.
Mattera PM; Faculty of Human and Social Sciences, Laboratory of Research in Psychopathology, 3 place André Leroy, 49008 Angers, France.
Peretti P; Faculty of Human and Social Sciences, Laboratory of Research in Psychopathology, 3 place André Leroy, 49008 Angers, France.
Levy A; Faculty of Human and Social Sciences, Laboratory of Research in Psychopathology, 3 place André Leroy, 49008 Angers, France.
Bernard L; Faculty of Human and Social Sciences, Laboratory of Research in Psychopathology, 3 place André Leroy, 49008 Angers, France.
Saiet M; Faculty of Human and Social Sciences, Laboratory of Research in Psychopathology, 3 place André Leroy, 49008 Angers, France.
Lagarce L; Departement of Pharmacovigilance, University Hospital Angers, Angers, France.
Briet M; Departement of Pharmacovigilance, University Hospital Angers, Angers, France.
Rivière M; French Lupus and Other Autoimmune Disease Patients Association, AFL+, Cuvry, France.
Pellier I; Department of Pediatrics, University Hospital Angers, Angers, France.
Gascoin G; Department of Neonatology, University Hospital Angers, Angers, France.
Rakotonjanahary J; Department of Pediatrics, University Hospital Angers, Angers, France.
Borghi MO; Clinical Immunology and Rheumatology Research Department Auxologico Institute, Milan, Italy.
Stojanovich L; Scientific Research Department, Internal Medicine-Rheumatology Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia.
Djokovic A; Scientific Research Department, Internal Medicine-Rheumatology Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia.
Stanisavljevic N; Scientific Research Department, Internal Medicine-Rheumatology Bezhanijska Kosa, University Medical Center, Belgrade University, Serbia.
Bromley R; Manchester University Hospitals NHS Trust, Manchester, UK; Division of Evolution and Genomic Science, School of Biological Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
Elefant-Amoura E; Genetical and Medical Embriology, CRAT Reference Center on Teratogenic Agents, Paris Est - Hôpital d'Enfants Armand-Trousseau, 26 avenue du Docteur Arnold Netter, 75571 Paris, France.
Bahi Buisson N; Neurology & Neurodevelopmental disorders Department Necker Enfants Malades University Hospital, APHP, Paris 149 Rue de Sèvres, 75015 Paris; INSERM U1163, Hôpital Necker Enfants Malades, 149 rue de Sèvres, 75015 Paris, France; INSERM U1163, Hôpital Necker Enfants Malades, 149 rue de Sèvres, 75015 Paris, France.
Pindi Sala T; EA 7334, Patient Centered Outcomes Research, University Paris Diderot, Paris, France.
Kelchtermans H; Synapse Research Institute, Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, the Netherlands.
Makatsariya A; Department of Obstetrics and Gynecology, I.M. Sechenow First Moscow State Medical University, Moscow, Russia.
Bidsatze V; Department of Obstetrics and Gynecology, I.M. Sechenow First Moscow State Medical University, Moscow, Russia.
Khizroeva J; Department of Obstetrics and Gynecology, I.M. Sechenow First Moscow State Medical University, Moscow, Russia.
Latino JO; Autoimmune and thrombophilic disorders Department, Hospital Carlos G. Durand, Buenos Aires, Argentina.
Udry S; Autoimmune and thrombophilic disorders Department, Hospital Carlos G. Durand, Buenos Aires, Argentina.
Henrion D; Internal Medicine Department, Clinique de l'Anjou, Angers, France.
Loufrani L; Internal Medicine Department, Clinique de l'Anjou, Angers, France.
Guihot AL; Internal Medicine Department, Clinique de l'Anjou, Angers, France.
Muchardt C; Unit of Epigenetic Regulation, Department of Developmental and Stem Cell Biology, UMR3738 CNRS, Institut Pasteur, Paris, France.
Hasan M; Cytometry and Biomarkers Unit of Technology and Service, Center for Translational Science, Institut Pasteur, 28, Rue Doct Roux, 75015 Paris, France.
Ungeheuer MN; Clinical Investigation and Acces to Bioresources Department, Institut Pasteur, 28, Rue Doct Roux, 75015 Paris, France.
Voswinkel J; Department of Internal Medicine I, Saarland Medical School, University of Saarland, Homburg, Saarland, Germany.
Damian L; Department of Rheumatology, County Emergency Hospital Cluj-Napoca, Cluj-Napoca, Romania.
Pabinger I; Department of Medicine, Division of Hematology and Haemostasis, University Hospital of Vienna, Austria.
Gebhart J; Department of Medicine, Division of Hematology and Haemostasis, University Hospital of Vienna, Austria.
Lopez Pedrera R; Institute Maimónides of Biomedical Investigations, University Hospital Reina Sofía, Cordoba, Spain.
Cohen Tervaert JW; Department of Medicine, Division of Rheumatology, University of Alberta, Edmonton, AB, Canada.
Tincani A; Rheumatology and Clinical Immunology Unit, University of Brescia, Brescia, Italy; I.M. Sechenow First Moscow State Medical University, Moscow, Russia.
Andreoli L; Rheumatology and Clinical Immunology Unit, University of Brescia, Brescia, Italy.
Pokaż więcej
Źródło :
Autoimmunity reviews [Autoimmun Rev] 2020 Sep; Vol. 19 (9), pp. 102525. Date of Electronic Publication: 2020 Mar 30.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Autoimmune Diseases/*drug therapy
Azathioprine/*administration & dosage
Azathioprine/*adverse effects
Pregnancy Complications/*drug therapy
Prenatal Exposure Delayed Effects/*chemically induced
Azathioprine/therapeutic use ; Child ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Immunosuppressive Agents/adverse effects ; Immunosuppressive Agents/therapeutic use ; Pregnancy ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Rare Genotype of His/His in NUDT15 Codon 139 and Thiopurine-associated Adverse Events in a Case of Ulcerative Colitis.
Autorzy :
Tomiyoshi K; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Sato H; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Tominaga K; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Kawata Y; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Okamoto D; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan.
Kakuta Y; Division of Gastroenterology, Tohoku University Graduate School of Medicine, Japan.
Yokoyama J; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Terai S; Division of Gastroenterology, Niigata University Medical and Dental Hospital, Japan.
Pokaż więcej
Źródło :
Internal medicine (Tokyo, Japan) [Intern Med] 2020 Jul 01; Vol. 59 (13), pp. 1611-1613. Date of Electronic Publication: 2020 Apr 09.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Azathioprine/*adverse effects
Colitis, Ulcerative/*drug therapy
Pyrophosphatases/*genetics
Alopecia/chemically induced ; Asian Continental Ancestry Group/genetics ; Azathioprine/pharmacokinetics ; Azathioprine/therapeutic use ; Codon ; Genetic Predisposition to Disease ; Genotype ; Humans ; Leukopenia/chemically induced ; Risk Factors
Czasopismo naukowe
Tytuł :
Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial.
Autorzy :
Roblin X; Department of Gastroenterology, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France.
Williet N; Department of Gastroenterology, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France.
Boschetti G; Department of Gastroenterology, Hospital Lyon-South, Pierre-Benite, France.
Phelip JM; Department of Gastroenterology, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France.
Del Tedesco E; Department of Gastroenterology, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France.
Berger AE; Department of Immunology, CIC 1408, GIMAP, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France.
Vedrines P; Gastro-enterology Department, Centre Hospitalier du Forez à Montbrison Instituts de Formation, Montbrison, Auvergne-Rhône-Alpes, France.
Duru G; Department of Statistics, UCBL, Villeurbanne, Auvergne-Rhône-Alpes, France.
Peyrin-Biroulet L; Department of gastroenterology, University Hospital Centre Nancy, Nancy, Lorraine, France.; INSERM U954, Nancy 1 University, Nancy, Lorraine, France.
Nancey S; Department of Gastroenterology, Hospital Lyon-South, Pierre-Benite, France.
Flourie B; Department of Gastroenterology, Hospital Lyon-South, Pierre-Benite, France.
Paul S; Department of Immunology, CIC 1408, GIMAP, CHU Saint-Étienne, Saint-Etienne, Rhône-Alpes, France .
Pokaż więcej
Źródło :
Gut [Gut] 2020 Jul; Vol. 69 (7), pp. 1206-1212. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Azathioprine/*therapeutic use
Immunosuppressive Agents/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Tumor Necrosis Factor-alpha/*antagonists & inhibitors
Adalimumab/administration & dosage ; Adalimumab/therapeutic use ; Adult ; Anti-Inflammatory Agents/administration & dosage ; Anti-Inflammatory Agents/therapeutic use ; Azathioprine/administration & dosage ; Crohn Disease/drug therapy ; Drug Therapy, Combination ; Female ; Humans ; Immunosuppressive Agents/administration & dosage ; Inflammatory Bowel Diseases/immunology ; Infliximab/administration & dosage ; Infliximab/therapeutic use ; Male ; Recurrence ; Treatment Outcome ; Tumor Necrosis Factor-alpha/immunology
Czasopismo naukowe
Tytuł :
New role for azathioprine in case of switching anti-TNFs in IBD.
Autorzy :
Papamichael K; Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA .
Cheifetz AS; Gastroenterology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Irving PM; Gastroenterology, Guy's and Saint Thomas' Hospitals NHS Trust, London, UK.
Pokaż więcej
Źródło :
Gut [Gut] 2020 Jul; Vol. 69 (7), pp. 1165-1167. Date of Electronic Publication: 2020 Feb 19.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Azathioprine*/adverse effects
Colitis, Ulcerative*/drug therapy
Humans ; Infliximab ; Prospective Studies ; Recurrence ; Tumor Necrosis Factor-alpha
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies